Title: Molecular mechanisms of 3,3'4,4',5-pentachlorobiphenyl-induced epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Journal: Toxicology and applied pharmacology20170501
Title: The evaluation of p,p'-DDT exposure on cell adhesion of hepatocellular carcinoma.
Journal: Toxicology20140801
Title: Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.
Journal: The Journal of biological chemistry20140502
Title: Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association20140201
Title: Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.
Journal: Basic research in cardiology20120501
Title: Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma.
Journal: Bioorganic & medicinal chemistry20111201
Title: Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Journal: Oncology reports20111101
Title: Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3.
Journal: Stem cells (Dayton, Ohio)20111101
Title: STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.
Journal: British journal of cancer20100525
Title: WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20080201
Title: WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Journal: Cancer research20071201
Title: A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Journal: Oncogene20070412
Title: Verstovsek S, et al. WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res, 2008, (3), 788-796.
Title: Hatiboglu MA, et al. The tumor microenvironment expression of p-STAT3 influences the efficacy of WP1066 in murine melanoma models. Int J Cancer, 2012, 131(1), 8-17
Title: Ferrajoli A, et al. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res, 2007, 67(23), 11291-11299.
